Package 70709-065-30

Brand: tascenso odt

Generic: fingolimod lauryl sulfate
NDC Package

Package Facts

Identity

Package NDC 70709-065-30
Digits Only 7070906530
Product NDC 70709-065
Description

3 BLISTER PACK in 1 CARTON (70709-065-30) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK

Marketing

Marketing Status
Marketed Since 2023-02-01
Brand tascenso odt
Generic fingolimod lauryl sulfate
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "eb717a3b-e703-4637-83c7-fccdecbac199", "openfda": {"upc": ["0370709062303"], "unii": ["J3HZQ9BE2S"], "spl_set_id": ["bf8e7f89-ea09-43c7-a7eb-e44724350721"], "manufacturer_name": ["Cycle Pharmaceuticals Ltd"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "3 BLISTER PACK in 1 CARTON (70709-065-30)  / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK", "package_ndc": "70709-065-30", "marketing_start_date": "20230201"}], "brand_name": "TASCENSO ODT", "product_id": "70709-065_eb717a3b-e703-4637-83c7-fccdecbac199", "dosage_form": "TABLET, ORALLY DISINTEGRATING", "pharm_class": ["Sphingosine 1-Phosphate Receptor Modulators [MoA]", "Sphingosine 1-phosphate Receptor Modulator [EPC]"], "product_ndc": "70709-065", "generic_name": "Fingolimod Lauryl Sulfate", "labeler_name": "Cycle Pharmaceuticals Ltd", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "TASCENSO ODT", "active_ingredients": [{"name": "FINGOLIMOD LAURYL SULFATE", "strength": ".5 mg/1"}], "application_number": "NDA214962", "marketing_category": "NDA", "marketing_start_date": "20230201", "listing_expiration_date": "20271231"}